[241 Pages Report] The global medical aesthetics market is projected to reach USD 15.9 billion by 2025 from USD 9.4 billion in 2020, at a CAGR of 10.9%. The growing adoption of minimally invasive and noninvasive aesthetic procedures, rising adoption among geriatric individuals, increasing public awareness about cosmetic procedures, the availability of technologically advanced & user-friendly products, and the increasing demand for aesthetic treatments among men are the key factors driving the growth of this market. On the other hand, market growth is limited to a certain extent by factors such as the clinical risks and complications associated with medical aesthetic procedures and the increasing availability and adoption of alternative beauty and cosmetic products.

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the global medical aesthetics market

The COVID-19 pandemic has significantly affected the medical aesthetics market. The beauty and luxury sector is facing challenges in its manufacturing and supply chain, such as delivering products to end users in a timely manner as well as attending to an uneven demand for products and services. The market is facing a period of short-term negative growth, which can be attributed to factors such as a decline in the product demand from major end users, limited operations in most of the industries, temporary closure of major end-user facilities (including beauty centers and spas), disrupted supply chain, and challenges in terms of providing essential/post-sales services due to the lockdown.

Driver: Growing adoption of minimally invasive and noninvasive aesthetic procedures.

In the past decade, there has been a significant increase in the preference for minimally invasive and noninvasive aesthetic procedures over traditional surgical procedures. Minimally invasive/nonsurgical alternatives offer various advantages over traditional surgical procedures, such as less pain, reduced scarring, and quicker recovery. These procedures are also more economical than traditional surgical procedures. As per the International Society of Aesthetic Plastic Surgery (ISAPS), there was an overall increase of 5.4% in the number of plastic and cosmetic procedures between 2017 and 2018.

Restraint: Clinical risks and complications associated with medical aesthetic procedures

In the past two decades, medical aesthetic procedures have become increasingly popular. The market has witnessed significant growth in the demand for aesthetic treatments owing to the rise in the number of doctors and surgeons providing safe and effective medical aesthetic treatments and the launch of technologically advanced products for the same. However, medical aesthetic procedures are associated with various possible side-effects. Patients undergoing aesthetic treatments may face several risks and complications after or during the procedure.

Opportunity: Emerging markets

Emerging countries such as China, Brazil, Mexico, and India present significant opportunities for players operating in the medical aesthetics market. The demand for medical aesthetic devices in these countries is increasing owing to a rapid growth in medical tourism, the growing adult (aged 20 and above) population, increasing disposable incomes, and growing awareness about aesthetic specialties. The presence of a large number of surgeons in these emerging countries is also contributing to the growth of the medical aesthetics market.

Challenge: Social and ethical issues associated with cosmetic treatments

Social stigmas associated with cosmetic treatments (surgical and nonsurgical) are mainly due to negative perceptions toward aesthetic procedures as well as the presence of religious and ethical concerns related to some aesthetic treatments, such as alterations, augmentations, erasures, and fillings. Although many people undergo some form of appearance-altering treatment, very few of them like to talk about it. Some people consider undergoing invasive anti-aging treatments, such as BOTOX or cosmetic surgery, as vain, self-centered, or being mentally unwell. Despite the increasing emphasis on looking younger among the elderly population, there are possible negative social consequences related to engaging in cosmetic age concealment. The social stigma attached to aesthetic treatments negatively affects the social acceptance of these procedures, thereby hindering the growth of this market.

By product type, the facial aesthetic product segment accounted for the largest share of the medical aesthetics market

On the basis of products, the market is segmented into facial aesthetic products (dermal fillers, botulinum toxin, microdermabrasion, and chemical peels); body contouring devices (nonsurgical fat reduction devices, cellulite reduction devices, and liposuction devices); cosmetic implants [breast implants (silicone implants and saline implants), facial implants, and gluteal cosmetic implants]; hair removal devices (laser hair removal devices and IPL hair removal devices); skin aesthetic devices (laser resurfacing devices, nonsurgical skin tightening devices, micro-needling products, and light therapy devices); tattoo removal devices; thread lift products; physician-dispensed cosmeceuticals and skin lighteners; physician-dispensed eyelash products; and nail treatment laser devices. The facial aesthetic products segment is expected to hold the largest share of the medical aesthetics market in 2019. The large share of this segment is attributed to the growing patient demand for facial aesthetic treatments, increasing disposable income and spending capabilities, and the rising geriatric population across the globe.

By end user, the clinics, hospitals, and medical spas segment accounted for the largest share of the medical aesthetics market

On the basis of end user, the medical aesthetics market is segmented into clinics, hospitals, and medical spas; beauty centers; and home care. The clinics, hospitals, and medical spas segment is estimated to account for the largest share of the global medical aesthetics market in 2019. This end-user segment is also expected to be fastest-growing end-user segment during the forecast period, owing to the increasing number of clinics and medical spas and the high availability of financial and infrastructural resources with hospitals, including technologically advanced devices, trained staff, and skilled professionals to perform aesthetic procedures.

North America accounted for the largest share of the medical aesthetics market in 2019

Geographically, this market is divided into North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. North America is expected to account for the largest share of the global medical aesthetics market in 2019, and this trend is expected to continue during the forecast period. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period. Rising consumer knowledge and interest in procedures, strong local economies, aggressive marketing by leading US and European companies in Asia, rising medical tourism, and increasing awareness about aesthetics are some of the key factors driving the growth of the medical aesthetics market in the Asia Pacific.

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

Allergan-AbbVie (US), Alma Lasers, Ltd. (Israel), Anika Therapeutics (US), Cutera, Inc. (US), Cynosure (US), El.En. S.p.A. (Italy), Fotona d.o.o. (Slovenia), Galderma (Switzerland), Johnson & Johnson (US), Merz Pharma GmbH & Co. KGaA (Germany), Medytox, Inc. (South Korea), Sientra, Inc. (US), Sinclair Pharma PLC (UK), Syneron Medical, Ltd. (US), and Baush Haealth (US) are some of the key players operating in the global medical aesthetics market.

Scope of the Report

Report Metric Details Market Size Available for Years 2018�2025 Base Year Considered 2019 Forecast Period 2020�2025 Currency Used Value (USD Million) Segments Covered Product Type, End-User and Region Geographies Covered North America, Europe, the Asia Pacific, Latin America, Middle East & Africa Companies Covered 15 major players, including Allergan-AbbVie (US), Alma Lasers, Ltd. (Israel), Anika Therapeutics (US), Cutera, Inc. (US), Cynosure (US), El.En. S.p.A. (Italy), Fotona d.o.o. (Slovenia), Galderma (Switzerland), Johnson & Johnson (US), Merz Pharma GmbH & Co. KGaA (Germany), Medytox, Inc. (South Korea), among others.

This report categorizes the global medical aesthetics market into the following segments and subsegments:

Medical Aesthetics Market, by Product

Facial Aesthetic Products Dermal Fillers Botulinum Toxin Microdermabrasion Chemical Peels

Body Contouring Devices Nonsurgical Fat Reduction Devices Cellulite Reduction Devices Liposuction Devices

Cosmetic Implants Breast Implants Silicone Implants Saline Implants Facial Implants Gluteal Implants

Hair Removal Devices Laser Hair Removal Devices IPL Hair Removal Devices

Skin Aesthetic Devices Laser Resurfacing Devices Nonsurgical Skin Tightening Devices Micro-needling Products Light Therapy Devices

Tattoo Removal Devices

Thread Lift Products

Physician-dispensed Cosmeceuticals and Skin Lighteners

Physician-dispensed Eyelash Products

Nail Treatment Laser Devices

Medical Aesthetics Market, by End User

Clinics, Hospitals, and Medical Spas

Beauty Centers

Home Care

Medical Aesthetics Market, by Region

North America US Canada

Europe Germany UK France Italy Spain Rest of Europe (RoE)

Asia Pacific Japan China India South Korea Australia Indonesia Thailand Rest of Asia Pacific (RoAPAC)

Latin America (LATAM) Brazil Mexico Rest of Latin America

Middle East and Africa

Recent Developments

In November 2020, AbbVie (US) acquired Allergan (Ireland) to form a global segment�Allergan Aesthetics in order to improve its medical aesthetics product line.

In January 2019, HRA Pharma (France) acquired Merz (Germany) to enhance its product portfolio in surgical medical aesthetics.

Frequently Asked Questions (FAQ):

What is the expected addressable market value of major medical aesthetics products over a 5-year period? Based on the prevailing trends and estimated market value data as of 2019, the total market value of major medical aesthetics products is estimated to be about USD 15.9 billion as of 2025. Which product categories are expected to have largest share in the medical aesthetics market? The facial aesthetic products segment is expected to hold the largest share of the medical aesthetics market in 2019. The large share of this segment is attributed to the growing patient demand for facial aesthetic treatments, increasing disposable income and spending capabilities, and the rising geriatric population across the globe. What are the opportunistic areas are available for new and existing players in the medical aesthetics market to enhance their market share? Emerging countries such as China, Brazil, Mexico, and India present significant opportunities for players operating in the medical aesthetics market. The demand for medical aesthetic devices in these countries is increasing owing to a rapid growth in medical tourism, the growing adult (aged 20 and above) population, increasing disposable incomes, and growing awareness about aesthetic specialties. The presence of a large number of surgeons in these emerging countries is also contributing to the growth of the medical aesthetics market. What are the major revenue pockets in the medical aesthetics market currently? North America is expected to account for the largest share of the global medical aesthetics market in 2019, and this trend is expected to continue during the forecast period. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period. Rising consumer knowledge and interest in procedures, strong local economies, aggressive marketing by leading US and European companies in Asia, rising medical tourism, and increasing awareness about aesthetics are some of the key factors driving the growth of the medical aesthetics market in the Asia Pacific. What are the key challenges for medical aesthetics products prevalent pertaining to the major end users? Social stigmas associated with cosmetic treatments (surgical and nonsurgical) are mainly due to negative perceptions toward aesthetic procedures as well as the presence of religious and ethical concerns related to some aesthetic treatments, such as alterations, augmentations, erasures, and fillings. Although many people undergo some form of appearance-altering treatment, very few of them like to talk about it. Some people consider undergoing invasive anti-aging treatments, such as BOTOX or cosmetic surgery, as vain, self-centered, or being mentally unwell. .

To speak to our analyst for a discussion on the above findings, click Speak to Analyst